Provoost, A.P.; Adejuyigke, O.; Wolff, E.D.: Nephrotoxicity of aminoglycosides in young adult rats. Pediat. Res. 19: 1191–1196 (1985).
Cowan, R.H.; Jukkola, A.F.; Arant, B.S., Jr.: Pathophysiologic evidence of gentamicin nephrotoxicity in neonatal puppies. Pediat. Res. 14: 1204–1211 (1980).
Feldman, H.; Guignard, J.P.; Plasma creatinine in the first month of life. Archs Dis. Childh. 57: 123- 126 (1982).
Gilman, A.G.; Goodman, L.S.; Rail, T.W.; Murad, F.: The pharmacological basis of therapeutics: 7th ed. (McMillan, New York 1985).
Whelton, A.: Renal tubular transport and intrare-nal aminoglycoside distribution; in Whelton, Neu, The aminoglycosides: microbiology, clinical use and toxicology, pp. 191–222 (Dekker, New York 1982).
Humes, H.D.; Sastrasinh, M.; Weinberg, J.M.: Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions, and dietary calcium supplementation protects against gentamicin nephrotoxicity. J. clin. Invest. 73: 134–147 (1984).
Bernard, A.; Viau, C.; Ouled, A.; Tulkens, P.; Lau-werijs, R.: Effect of gentamicin on the renal uptake of endogenous and exogenous proteins in conscious rats. Toxicol, appl. Pharmacol. 84:431–438 (1986).
Silverblatt, F.J.; Kuehn, C.: Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney int. 15: 335–345 (1979).
Bennet, W.M.; Plamp, C.E.; Eliott, W.C.; Parker, R.A.; Porter, G.A.: Effect of basic amino acid and aminoglycosides or 3H-gentamicin uptake in cortical slices of rat and human kidney. J. Lab. clin. Med. 99: 156–162 (1982).
Laurent, G.; Maldague, P.; Carlier, M.B.; Tulkens, P.: Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob. Agents Chemother. 24:586–593 (1983).
Schentag, J.J.; Gengo, F.M.; Plaut, M.E.; Danner, D.; Mangione, A.; Jusko, W.J.: Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides. Antimicrob. Agents Chemother. 16: 468–474 (1979).
McNeil, J.S.; Jackson, B.; Nelson, L.; Butkus, D.E.: The role of prostaglandins in gentamicin-induced nephrotoxicity in the dog. Nephron 33: 202–207 (1983).
Luft, F.C.; Evans, A.P.: Comparative effect of tobramycin and gentamicin on glomerular ultrastructure. J. infect. Dis. 142: 910–914 (1980).
Porter, G.A.; Eliott, W.C.; Bennett, W.M.; McClung, M.; Further evaluation of the polyuria associated with experimental aminoglycoside nephrotoxicity; in Fillastre, Nephrotoxicity ototoxicity of drugs, pp. 95–108 (INSERM. Rouen 1982).
McCracken, G.H.; Jones, L.G.: Gentamicin in the neonatal period. Am. J. Dis. Child. 120: 524–533 (1970).
McCracken, G.H., Jr.: Aminoglycoside toxicity in infants and children. Am. J. Med. 80: suppl. 6B, pp. 172–178 (1986).
Vanderlinde, R.E.: Urinary enzyme measurements in the diagnosis of renal disorders. Am. clin. Lab. Sci. 11: 189–201 (1981).
Kunin, C.M.; Chesney, R.W.; Graig, W.A.; England, A.C.; De Angelis, C.: Enzymuria as a marker of renal injury and disease: studies of N-acetyl-()-glucosaminidase in the general population and in patients with renal disease. Pediatrics 62: 751–760(1978).
Adelman, R.D.; Zakauddin, S.: Urinary enzyme activities in children and neonates receiving gentamicin therapy. Dev. Pharmacol. Ther. 1: 325–332 (1980).
Lockwood, T.D.; Bosmann, H.B.: The use of urinary N-acctyl-p-glucosaminidase in human renal toxicology. I. Partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidney. Toxicol, appl. Pharmacol. 49: 323–336 (1979).
Jung, K.; Schulze, G.; Rcinholdt, C.: Different diuresis-dependant excretions of urinary enzymes: N-acetyl-D-7-glucosaminidase, alanineaminopeptidase, alkaline phosphatase, and alpha-glutamyltransferase. Clin. Chem. 32: 529–532 (1986).
Tucker, S.M.; Pierce, R.J.; Price, R.G.: Characterisation of human N-acetyl-(i-/J-glucosaminidase) isoenzymes as an indicator of tissue damage in disease. Clinica chim. Acta 102: 29–40 (1980).
Dupond, J.L.; Gibey, R.; Ichl-Robert, M.; Mallet, H., Leconte des Floris, R.; Henry, J.C.: Nephro-toxicite des aminosides et cephalosporines. In-teret de l’etude des profils iso-enzymatiques de la N-acetyl-p-D-glucosaminidase (NAG). Revue m6d. int. 5: 321–327 (1984).
Agosti, S.; Assael, B.M.; Masturzo, P.; Santarone, M.R.; Salmona, M.: N-acetyl-p-/7-glucosamini-dase (NAG) levels in amniotic fluid or urine in prenatal and postnatal life. Early hum. Dev. 14: 229–232 (1986).
Langhendries, J.P.; Gillain, N.; Battisti, O.; Car-lier, B.; Bertrand, J.M.: Normal values for urinary N-acetyl-beta-glucosaminidase excretion in preterm and term babies. Archs Dis. Childh. 62:483–486 (1987).
Sutphen, J.L.: Anthropometric determinants of creatinine excretion in preterm infants. Pediatrics 69: 719–723 (1982).
Parini, R.; Ruscani, F.; Gavanna, G.; Vigliani, E.; Cornacckia, L.; Assael, B.M.: Evaluation of the renal and auditory functions of neonates treated with amikacin. Dev. Pharmacol. Ther. 5: 33–46 (1982).
Rajchgot, P.; Prober, C.G.; Soldin, S.; Perlman, M.; Good, F.; Harding, E.; Klein, J.; McLeod, S.: Aminoglycoside-related nephrotoxicity in the premature newborn. Clin. Pharmacol. Ther. 35: 394–401 (1984).
Langhendries, J.P.; Mattot, M.; Francois, A.; De-prez, D.; Battisti, O.; Bertrand, J.M.; Schoos, S.: Validity of urinary N-acetyl-bcta-D-glucosamini-dase (NAG) determination in assessing netilmicin nephrotoxicity in preterm babies (submitted, 1987).
Just, M.; Erdmann, G.; Habermann, E.: The renal handling of polybasic drugs. 1 Gentamicin and aprotinin in intact animals. Arch. Pharmacol. 300: 57–66 (1977).
